John McPherson, MD

The XIENCE V EXCEED Trial: Acute Performance, Deliverability and Resource Utilization in the Cath Lab

02/11/2010

Can you describe the EXCEED trial and its purpose? There are two components of the post-marketing evaluation of Abbott’s Xience V stent. First is the Xience V USA program, which is looking at long-term clinical outcomes in about 8,000...

Can you describe the EXCEED...

02/11/2010

Cath Lab Digest

Original Contribution

Effects of the Number and Interval of Balloon Inflations during Primary PCI (Full title below)

09/01/2009

John McPherson , MD;

David X. Zhao , MD;

Guisong Wang , MD;

Sanguo Zhang , MD;

Steven J. Joggerst , MD;

Effects of the Number and Interval of Balloon Inflations during Primary PCI on the Extent of Myocardial Injury in Patients with STEMI: Does Postconditioning Exist in Real-World Practice? ____________________________ ABSTRACT:...

Effects of the Number and...

09/01/2009

Journal of Invasive Cardiology